The TBMED consortium consists of 13 partners from four European countries. The collective expertise, committment and prior research track record of the partners involved, which were specifically selected for their diverse experience and essential competencies as well as for their complementarity guarantees the successful implementation of the project and the creation of the OITB as a separate legal entity afterwards.